TVTX
Travere Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TVTX fundamentals
Travere Therapeutics (TVTX) released its earnings on Oct 30, 2025: revenue was 164.86M (YoY +162.10%), beat estimates; EPS was 0.59 (YoY +184.29%), beat estimates.
Revenue / YoY
164.86M
+162.10%
EPS / YoY
0.59
+184.29%
Report date
Oct 30, 2025
TVTX Earnings Call Summary for Q3,2025
- Revenue Surge: FILSPARI sales up 155% YoY to $90.9M, driven by guideline adoption and REMS simplification.
- FSGS Approval Path: FDA clears way for January 2026 approval, with no advisory committee needed.
- Global Expansion: Japan's Chugai acquisition of Renalys accelerates sparsentan trials; Europe sees expanded access via CSL Vifor.
- Financial Strength: $254.5M cash, no near-term capital needs, and non-GAAP net income up 48% YoY.
- Pipeline Momentum: Pegtibatinase manufacturing complete; HARMONY study restarts in 2026 for classical HCU.
EPS
Revenue
Revenue & Expenses
TVTX has released its 2025 Q3 earnings report, with revenue of 164.86M, reflecting a YoY change of 162.11%, and net profit of 25.71M, showing a YoY change of 146.90%. The Sankey diagram below clearly presents TVTX's revenue sources and cost distribution.
Key Indicators
Travere Therapeutics (TVTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Travere Therapeutics (TVTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Travere Therapeutics (TVTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Travere Therapeutics (TVTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Travere Therapeutics (TVTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Travere Therapeutics (TVTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Travere Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Travere Therapeutics year over year?What does Travere Therapeutics do and what are its main business segments?What were the key takeaways from Travere Therapeutics’s earnings call?What is the market's earnings forecast for Travere Therapeutics next quarter?Did Travere Therapeutics beat or miss consensus estimates last quarter?What is Travere Therapeutics's gross profit margin?What is Travere Therapeutics's latest dividend and current dividend yield?
